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concentrations give no suggestion of the sufficient number of molecules per cell and are confusing when referring to physiolog-
ical situations in which signaling molecules act in an immobilized state. Here, we studied platelet adhesion by thrombin, a key
step in normal hemostasis and pathological arterial thrombosis. We generated a biofunctional nanosheet surface to mimic the
in vivo solid-state interaction between platelets and thrombin at sites of injured tissues. We observed that<10 molecules readily
activate platelets with high specificity, resulting in platelet adhesion and spreading. This number is much lower than expected
from previous experiments in solution, in which the sole activation of platelets required a >1000-fold stoichiometric excess of
thrombin. We conclude that immobilizing thrombin apposed to the membrane receptor allows platelets to respond with very
high sensitivity. Moreover, we propose that irreversible cell activation may require several ligands to avoid activation by single,
mislocalized signaling molecules.INTRODUCTIONOrganisms respond to signal-triggering molecules with
impressively high sensitivities in the nanomolar or even
picomolar concentration range (1,2). At concentrations of
several picomolar, one molecule occupies a volume equiva-
lent to the size of a small cell, which intuitively suggests that
only a few molecules may be sufficient for activation.
However, more important than the molecular density seen
by the cell is the number of effective molecules, which
depends on the binding affinity of the signaling molecule
to the receptor, the receptor density, the incubation time,
and whether the fraction of activated receptors can produce
a sufficiently strong intracellular signal. These issues make
it difficult to predict the number of necessary molecules
from a given concentration associated with cell activation.
Therefore, estimates have been obtained for only a few
cases; for example, Ueda and Shibata (3) reported that
several thousand receptors per cell are occupied during
picomolar-sensitive chemotaxis.
Although activating concentrations are already difficult to
interpret, the situation becomes even more complex when
ligands become immobilized before they interact with recep-
tors. One such example is the activation of platelets by
thrombin, a key step in normal hemostasis and pathological
arterial thrombosis (4,5) resulting in platelet adhesion,
spreading, and aggregation. A concentration of 0.5 nM
thrombin (6) has been reported to be associated with the tran-
sition from the nonactivated to the activated statewhen plate-Submitted October 6, 2010, and accepted for publication February 28,
2011.
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0006-3495/11/04/1855/9 $2.00lets and thrombin are incubated in solution, corresponding to
a thrombin/platelet ratio of ~1200:1. However, for adhesion
under physiological conditions, a variety of mechanisms
recruit platelets from the bloodstream and immobilize them
at sites of vascular injuries (7). Such sites are marked by
exposed basal laminal collagen from the subendothelial
matrix, to which platelets bind directly or indirectly via
glycoprotein (GP) surface receptors. At this stage, thrombin
interacts with platelets not only in solution but also in a solid-
state configuration in which thrombin is immobilized at the
subendothelial matrix (8) and the surface of activated endo-
thelial cells (9). In addition, thrombin may be directly
involved in platelet recruitment by binding to the platelet
surface receptor GPIba (10). Once the thrombin molecules
and platelets are closely apposed to each other, thrombin trig-
gers platelet activation by switching on G-protein coupled
receptors from the protease activated receptor (PAR) family.
To this end, thrombin cleaves PAR-1 (and also PAR-4),
producing a new receptor N-terminus that intramolecularly
binds to the ligand-binding site, representing a receptor
locked in the on state (11).
Under these conditions, the concentration required for acti-
vation would be best described by a surface concentration or
a defined number of immobilized thrombin molecules per
apposed platelet. To determine this number, we set up an
assay system in which platelets were allowed to establish
contact with a thrombin-coated surface (12). For stable
thrombin adsorption, we turned to free-standing hydrophobic
poly-L-lactic acid (PLLA) nanosheets with a thickness of
60 nm (13), which for microscopic analysis were attached
to glass coverslipswithout any adhesive reagent. PLLAnano-
sheets provide a hydrophobic surface to which proteins can
stably adsorb by hydrophobic interactions. Moreover, theydoi: 10.1016/j.bpj.2011.02.052
1856 Okamura et al.do not disturb microscopic analysis by fluorescence, they
provide an inert surface that cannot trigger unspecific platelet
activation, and they can be removed again from the coverslip
to analyze the amount and activity of the adsorbed protein.MATERIALS AND METHODS
Preparation of nanosheets
We prepared 60-nm-thick PLLA nanosheets essentially as described previ-
ously (13). First, to produce a water-soluble sacrificial layer, we pipetted an
aqueous solution of 10 mg/ml polyvinyl alcohol (PVA, molecular mass
22 kDa, 99% hydrolyzed; Kanto Chemical, Tokyo, Japan) onto 4 cm 
4 cm SiO2 wafers (P-type Si (100) wafers covered with thermally grown
silicon oxide (SiO2); KST World, Fukui, Japan). The wafers were spin-
coated at 4000 rpm (spin coater IH-D3; Mikasa Ltd., Tokyo, Japan) for
20 s and then dried at 70C for 90 s. Using the same procedure, we then
coated the PVA-coated SiO2 wafers with 10 mg/ml PLLA in methylene
chloride (molecular mass 80–100 kDa; Polysciences, Warrington, PA).
Next, we detached the PLLA nanosheets from the wafers by dissolving
the PVA sacrificial layer with water and picked up the floating nanosheets
with a glass coverslip (25 mm diameter for adhesion studies, and 12 mm for
experiments in which fluorescent nanosheets were imaged), forming
a coverslip with a tightly attached nanosheet. Finally, the preparation was
dried overnight at 70C.
Detachable nanosheets were prepared by sandwiching a water-soluble
sacrificial PVA layer between the PLLA nanosheets and the coverslips.
To this end, 12-mm-diameter coverslips were directly coated with PVA
followed by PLLA coating.Protein-nanosheet adsorption
The thrombin solutions used for coating contained thrombin or fluorescent-
labeled thrombin in phosphate-buffered saline (PBS; 2.7 mM KCl, 1.5 mM
KH2PO4, 137 mM NaCl, 8.1 mM Na2HPO4, pH 7.4) at a concentration as
indicated (referring to units as quoted by the supplier; bovine thrombin,
catalog No. T4648, lot No. 025K76356; Sigma-Aldrich, Saint Louis,
MO). For fluorescent labeling of the thrombin solution, we used tetra-
methyl-rhodamine iso-thio-cyanate (TRITC, catalog No. T2639; Sigma-Al-
drich), adding 5–20 ml of 10 mM TRITC in DMSO to 1 ml of a 100 U/ml
thrombin solution in PBS. The mixture was incubated for 1 h at room
temperature (RT) and the nonreacted dye was separated from the protein
by gel filtration using a Sephadex G25 column (GE Healthcare UK, Buck-
inghamshire, UK).
For coating, the thrombin solutions were pipetted directly onto the nano-
sheets (100 ml and 500 ml were applied to 12- and 25-mm-diameter cover-
slips, respectively) and incubated overnight at 4C. For the adhesion
studies, 10 U/ml of thrombin coating were applied overnight or for at least
for 3 h (no difference in adhesion was observed). Finally, the coverslips
were carefully rinsed three times with PBS and incubated with 3% (w/v)
bovine serum albumin (BSA; Sigma-Aldrich) in PBS at 4C for 2 h (this
step was omitted in experiments using detachable nanosheets or when
fluorescent-labeled sheets on a coverslip were imaged). We evaluated the
stability of the thrombin adsorption by using a coating of 0.1 U/ml
TRITC-labeled thrombin. After coating was completed, we performed
one to six 5-min washing steps and analyzed the average fluorescence inten-
sity by fluorescence microscopy. The results showed no significant loss of
protein during a total washing period of 30 min (data not shown).Platelet adhesion assay
We added 10% (v/v) of a 3.8% (w/v) sodium citrate solution to blood drawn
from healthy volunteers after they provided written informed consentBiophysical Journal 100(8) 1855–1863according to the guidelines of the institutional review board of the Univer-
sity of Bonn. An initial centrifugation step (120 g, 15 min, 22C) yielded
platelet-rich plasma in the supernatant, to which a 15% volume of an acid-
citrate-dextrose solution (2.2% (w/v) sodium citrate, 0.8% (w/v) citric acid,
2.2% (w/v) glucose, and 2 mM prostaglandin E1 (PGE1, catalog No. P5515;
Sigma-Aldrich)) was added. After centrifugation (1500  g, 7 min, 22C),
the platelets were resuspended in Ringer’s citrate-dextrose solution (0.76%
(w/v) citric acid, 0.090% (w/v) glucose, 0.043% (w/v) MgCl2, 0.038%
(w/v) KCl, 0.60% (w/v) NaCl, 2 mM PGE1, pH 6.5) and spun down again
(1500 g, 7 min, 22C). The remaining pellet was resuspended in HEPES-
Tyrode buffer (5.6 mM glucose, 2.7 mMKCl, 1 mMMgCl2, 137 mMNaCl,
12 mM NaHCO3, 0.4 mM NaH2PO4, 10 mM HEPES, pH 7.4) containing
1 mM CaCl2, with the concentration adjusted to 2.0  105 platelets/ml
for the platelet adhesion assay.
To test whether the platelets were already activated after purification, we
analyzed the amount of P-selectin that mobilized to the cell surface. After
purification, 50 ml suspensions of 1.0  105 platelets/ml were incubated at
37C for up to 90 min. As a positive control, one suspension was incubated
for 10 min with the addition of 0.25 U/ml thrombin. Then 0.13 mg FITC-
labeled mouse anti-human P-selectin antibody (catalog No. 555523; BD
Biosciences, San Diego, CA) or FITC-labeled mouse IgG k isotype control
(catalog No. 555748; BD Biosciences), as a control for unspecific antibody
binding, were added followed by a 5 min incubation at RT and fixation by
formaldehyde (1.5% (v/v)). Platelets were gated to their characteristic
forward versus side scatter. We then measured the fraction of positive cells
in 10,000 platelets using fluorescence-activated cell sorting (FACSCanto II
flow cytometer; BD Biosciences, San Jose, CA) and analyzed the results
with FlowJo software (TreeStar, Ashland, OR).
For the adhesion experiments, 500 ml platelet suspensions were trans-
ferred onto coverslip adsorbed nanosheets that were incubated in six-well
plates for various time periods as indicated, and maintained at 37C with
a water bath. Where indicated, before the platelets were incubated with
the nanosheets, platelets in HEPES-Tyrode buffer (containing 1 mM
CaCl2) and/or nanosheets in PBS were treated with the following reagents:
Hirudin (recombinant hirudin from yeast, catalog No. 94581; Sigma-Al-
drich), N3-cyclopropyl-7-[[4-(1-methylethyl) phenyl]methyl]-7H-pyrrolo
[3,2-f]quinazoline-1,3-diamine dihydrochloride (SCH79797; catalog No.
1592; Tocris Bioscience, Ellisville, MO; SCH79797 was dissolved in
DMSO and in the corresponding control condition the buffer also contained
DMSO), D-Phe-L-Pro-L-Arg chloromethyl ketone dihydrochloride
(PPACK, catalog No. 520222; Merck KGaA, Darmstadt, Germany), anti-
GPIba monoclonal antibody (SZ2; Beckman Coulter, Brea, CA), RGDS
peptide (catalog No. A9041; Sigma-Aldrich), or ReoPro (license number
for Germany 100a/94, manufactured by Centocor B.V., Leiden, The
Netherlands). We washed off nonadherent platelets at RT by gently adding
several milliliters of PBS, and further rinsed the coverslips two times with
PBS. The cells were then fixed with 4% (w/v) paraformaldehyde (PFA) in
PBS at 4C for 90 min, quenched with 50 mM NH4Cl in PBS at RT for
10 min, and washed three times with PBS for 5 min each.
In some experiments, samples were also immunostained for GPIIb to
obtain additional information for the identification of platelets. To this
end, platelets were permeabilized with Triton X-100 in PBS at RT for
10 min (using 0.5% Triton for Fig. 2 and Fig. S3 in the Supporting
Material), and incubated at RT for 45 min with monoclonal mouse anti-
human GPIIb antibody (catalog No. 555466; BD Biosciences) diluted
1:100 in 3% (w/v) BSA-PBS containing Triton X-100 (0.2% for Fig. 2 and
Fig. S3). Subsequently, the cells were rinsed three times in PBS for 10 min
each, followed by a 45 min incubation with a secondary antibody diluted
in 3% BSA-PBS containing Triton X-100 (0.2% for Fig. 2 and Fig. S3).
We used 1:200 diluted Alexa594 labeled donkey-anti-mouse (A21203,
Invitrogen, Eugene, OR) for Fig. S3, and 1:50 diluted KK114-conjugated
sheep anti-mouse IgG (obtained from the Department of NanoBiophotonics,
Max Planck Institute for Biophysical Chemistry, Go¨ttingen, Germany) for
Fig. 2. The coverslips were washed three times in PBS for 10 min each.
For stimulated emission depletion (STED) microscopy, samples were ship-
ped in 4%PFA inPBS to theMaxPlanck Institute forBiophysicalChemistry.
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For epifluorescence imaging, we used a total internal reflection fluorescence
(TIRF) microscope (based on a motorized Olympus IX81 microscope;
Olympus, Tokyo, Japan) equipped with an EMCCD camera (ImagEM
C9100-13; Hamamatsu Photonics, Hamamatsu, Japan), a 488 nm laser,
and a 150 W Xenon lamp integrated into the MT20-I-fluorescence illumi-
nation system. We used the microscope in epifluorescence mode by
applying a 60 NA 1.49 Apochromat objective in combination with
a 2 magnifying lens. For fluorescence excitation, the Xenon lamp was
used at 100% intensity, and the Olympus filter set U-M3DAFIC3/HC was
used for N,N,N-tri-methyl-4-(6-phenyl-1,3,5-hexa-trien-1-yl) phenyl-
ammonium p-toluene-sulfonate (TMA-DPH; Sigma-Aldrich) and
Alexa594 detection. The exposure times were 200 ms for Alexa594 and
1 s for TMA-DPH.
Imaging was performed in PBS containing TMA-DPH to visualize phos-
pholipid membranes. For each condition, we recorded three to six images
and analyzed the surface covered by activated platelets using the TMA-
DPH image as reference. To this end, images were manually thresholded
in Image J (National Institutes of Health, Bethesda, MD), and the area
covered by platelets divided by the total image area yielded the percentage
of area covered by platelets. For each condition, values obtained from indi-
vidual images were averaged. In some experiments, using inverted images
we also manually counted the number of platelets per field of view.Quantification of adsorbed protein
Detachable PLLA nanosheets on 12-mm coverslips were coated with
TRITC-labeled thrombin solutions as indicated. The supernatants were
collected and coverslips were carefully rinsed three times with PBS. An
incision at the edge of the coverslips was made with tweezers to facilitate
the nanosheet detachment in PBS containing 1% sodium dodecyl sulfate
(SDS; Carl-Roth GmbH, Karlsruhe, Germany). The detached nanosheets
were transferred into 96-well plates, and fluorescence (Ex ¼ 540 nm,
Em¼ 580 nm) was measured with a spectrophotometer (Infinite 200; Tecan
Group Ltd., Ma¨nnedorf, Switzerland). We determined the amount of total
adsorbed protein by referring to calibration measurements with TRITC-
labeled thrombin solutions containing in addition uncoated nanosheets
and 1% SDS in PBS. In addition, we measured the loss of protein from
the coating solution. To this end, we diluted the labeled protein with 1%
SDS in PBS to the corresponding coating concentrations and measured it
to obtain the value before coating. After coating was completed, the super-
natants were diluted 1:10 and 1:100 with 1% SDS in PBS and measured.
The values were corrected for evaporation that occurred during overnight
incubation, yielding the amount of protein in the coating solution after
coating. Subtraction of both values yielded the amount of protein lost
from the coating solution. For one individual experiment, the two values
(i.e., the amount on the nanosheet and the amount of lost protein) were aver-
aged and used for plotting.Imaging of fluorescent protein-coated
nanosheets
Nanosheets on 12-mm-diameter coverslips with no sacrificial layer were
coated with a 0.26 U/ml TRITC-labeled thrombin solution. For imaging,
the coverslips carrying the nanosheets were placed on larger coverslips
(25 mm diameter) mounted in a microscopy chamber that was filled with
PBS. For imaging, we used an Olympus IX81 microscope (see above)
applying a 10  0.4 NA Apochromat objective in the epifluorescence
mode. We used the Xenon lamp at 100% intensity for fluorescence excita-
tion, and the Olympus filter set U-M3DAFIC3/HC for TRITC detection.
The exposure time was 200 ms and the camera gain was set to one. Images
were taken from the periphery of the nanosheets. From each nanosheet, two
to eight images were taken for analysis, and five to 10 values per imagewere determined for the inner and rim areas. To determine the width of
the rim, we analyzed 15 linescans per nanosheet. Images were analyzed
with the use of Image J software (National Institutes of Health).SDS-PAGE
Samples together with BSA standards in 1.6% SDS were subjected to 12%
(w/v) nonreducing SDS-PAGE. Polyacrylamide gels were stained with
colloidal Coomassie. Fluorescence of the Coomassie dye induced by
protein binding (14,15) was excited by a solid-state diode laser at
680 nm using the Odyssey Infrared Imaging System (Li-Cor Biosciences),
which was also used for quantitation of the band intensities.
Mass spectrometry of excised bands was performed by the Proteomics
Facility of the Cluster of Excellence, Cellular Stress Responses in Aging-
Associated Diseases, University of Cologne (Cologne, Germany).Activity of adsorbed thrombin
Thrombin activities were assayed in 150 mM imidazole buffer (pH 7.0)
using N-(p-tosyl)-Gly-Pro-Arg-p-nitroanilide acetate salt (catalog No.
T1637; Sigma-Aldrich) as a chromogenic substrate of thrombin. In addi-
tion, the assay buffer contained 0.01% Tween 20 to avoid nanosheet flota-
tion. For analysis of thrombin activity in solution, 290 ml buffer aliquots in
a 96-well plate contained substrate concentrations ranging from 0.031 to
1.0 mM or no substrate. After 10 min preincubation at 32C, the reaction
was initiated by addition of 10 ml thrombin protein solution (corresponding
to 601 ng). To measure the activity of thrombin in the coated state, 300 ml
buffer aliquots were incubated in 96-well plates and the reaction was initi-
ated by adding the detached nanosheet (coated with 327 ng protein, as
determined from Fig. 4). Under both assay conditions, the change in A405
was continuously monitored with the use of a spectrophotometer (Infinite
200) at 32C. For each substrate concentration (S) the slope of the initial
trace (velocity of product formation ¼ V; an absorption coefficient of 4-ni-
troanilide 9500 M1 cm1 was used) was determined, 1/V was plotted
versus 1/S, and a linear regression line was fitted. The point of intersection
of the regression line with the y axis yielded 1/Vmax, and Vmax was used as
a reference for thrombin activity.isoSTED microscopy
When the samples arrived at the Max Planck Institute for Biophysical
Chemistry (Go¨ttingen, Germany), the PFA was quenched for 10 min at
RT by a PBS solution containing 50 mM NH4Cl. For isoSTED imaging
(16), the PBS buffer was exchanged by a dilution series with 2,20-thiodie-
thanol in PBS (17), resulting in an embedding medium of 97% (v/v) 2,20-
thiodiethanol in PBS. The sample was covered with a second coverslip
that was sparsely coated with fluorescent beads (crimson fluorescent micro-
spheres, specified diameter 100 nm; Molecular Probes, Eugene, OR) to
facilitate the initial alignment of the isoSTED microscope. Excitation at
a wavelength of 635 nm was performed with a pulsed semiconductor laser
(PDL 800-B with LDH-P-C 635b; PicoQuant, Berlin, Germany) that deliv-
ered <100 ps excitation pulses synchronized with STED pulses of ~1 ns
length. The source of the STED light was a frequency-doubled fiber laser
(ELP-5-775-DG; IPG Photonics, Oxford, MA) operating at 20 MHz and
a wavelength of 775 nm. The time-averaged STED power in the sample
was ~100 mW. The emission of the fluorophore KK114 was detected in
the 660–700 nm wavelength range with the use of a photon-counting
avalanche photodiode (PerkinElmer, Waltham, MA).
To analyze cluster size and density, we recorded images using a spherical
point spread function and exported, rescaled, and filtered them with the blur
filter (10%) in MetaMorph (Universal Imaging, West Chester, PA). We then
cut out representative 100 100 pixel areas of 1.42 mm 1.42 mm from the
image of the cells. We identified individual clusters in these areas usingBiophysical Journal 100(8) 1855–1863
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of identified clusters divided by the area. We then fitted each cluster with
a Gaussian, taking into account a homogeneous background. We rejected
fits that showed either a background of >10 photons or a center that devi-
ated>21.3 nm from the initial guess of the cluster’s center. The signal/noise
ratios varied largely between the different experiments and we observed
a trend toward smaller clusters at lower signal/noise ratios. To avoid under-
estimating the cluster size, we present the data from the experiment with the
highest signal/noise ratio, from which 12 cells from four recordings were
analyzed. In this set of experiments, we identified a total of 814 clusters
from 12 cells. From 376 clusters, we obtained the size by fitting a Gaussian
(in this case, fitting was repeated on unfiltered raw data). The cluster size
and density are given as the mean5 standard deviation (SD; n ¼ 12 cells).
To acquire an xz scan of the platelets (see Fig. 2, upper panel), we config-
ured the point spread function of the microscope into an oblate shape (18).
We then nonlinearly deconvolved the recorded data by applying 30 itera-
tions of the Richardson-Lucy algorithm (19) to account for blurring effects
of the imaging system.TIRF microscopy
For measurement of the platelet contact area, platelets were settled down
onto nanosheets coated overnight at 4C with 3% BSA in PBS. Cells
were incubated for 10 min at 37C and then fixed with 4% (w/v) PFA in
PBS at 4C for 90 min. PFA was quenched at RT by gentle addition of
a 10% volume of PBS containing 500 mM NH4Cl for 10 min. Then the
coverslips were mounted in a microscopy chamber and platelets were
imaged in the presence of 5 mM N-(3-tri-ethyl-ammonium-propyl)-4-(4-
(di-butyl-amino)-styryl)-pyridinium di-bomide (FM1-43; Invitrogen) in
PBS to visualize their membranes. For imaging, we used a TIRF micro-
scope (using a 60 NA 1.49 Apochromat objective in combination with
a 2 and 1.6 magnifying lens; see above). We used a 488 nm laser line
for TIRF illumination at 100% intensity in combination with Olympus filter
U-MTIR488-HC. For epifluorescence, we used a Xenon lamp at 100%
intensity with Olympus filter U-M3DAFIC3/HC. We first imaged the fields
of view using epifluorescence and then acquired an image under TIRF illu-
mination. For image analysis, we used the program Corel-Draw. Using the
epifluorescence image as reference, we identified the contact areas in the
TIRF image, outlined them manually, and determined their size using
Image J with a TIFF image exported from Corel-Draw. Contact areas
from spontaneously activated platelets were not included. For each cover-
slip, we recorded five to seven images. Two to four of these images were
then used for analysis. Three independent experiments were performed.RESULTS AND DISCUSSION
First, we tested whether thrombin-coated nanosheets indeed
represent functionalized surfaces that can trigger specific
platelet adhesion and spreading. At physiological tempera-
ture, purified platelets were allowed to settle down onto
nanosheets coated with 10 U/ml thrombin and washed off
after variable times, leaving attached platelets that under-
went adhesion. As shown in Fig. 1 A, shortly after incu-
bation we observed platelets with filopodial and
lamellipodial extensions, representing intermediate states
on the pathway to full spreading. The extent of platelet
adhesion was time-dependent, and the process was
completed in 10 min, when maximal surface coverage by
fully spread platelets was achieved (Fig. 1, A and B). To
exclude cell priming before incubation with nanosheets,
we used fluorescence-activated cell sorting to determineBiophysical Journal 100(8) 1855–1863whether P-selectin had been mobilized from a-granules to
the cell surface. P-selectin on the surface of purified plate-
lets incubated for variable times was fluorescently labeled
by antibodies, and the percentage of positive cells was deter-
mined. As presented in Fig. S1, after 60 min a very minor
percentage (~0.7%) of the platelets were positive for surface
P-selectin, excluding platelet activation at the moment they
were added to the nanosheets, which was either directly
after purification or after a maximal 15 min pretreatment
(e.g., Fig. 1 E).
We then sought to determine whether platelets adhere and
spread specifically due to thrombin activation, and which
adhesion molecule is involved in the adhesion process. As
depicted in Fig. 1, C–E, during the 10 min incubation the
platelets did not adhere when nanosheets were coated with
BSA, when thrombin was treated with the thrombin inhib-
itor hirudin (20) before platelet addition, or when the plate-
lets were treated with the PAR-1 receptor antagonist
SCH79797 (21). Hence, platelet adhesion is clearly trig-
gered by a pathway involving activation by thrombin.
Because thrombin also binds to GPIba on the platelet
surface (10), we assessed the extent to which such an inter-
action might underlie the observed process. As shown in
Fig. 1, F and G, we did not observe any effect when the
thrombin-GPIba-interaction was blocked by GPIba anti-
bodies, consistent with the previous finding that activation
via thrombin binding to GPIba is unnoticed due to the
stronger activation via PARs (10). Inhibition of the thrombin
protease activity by PPACK resulted in binding and forma-
tion of filopodial extensions of a very small fraction of plate-
lets (<2% surface coverage) without full spreading. This
mode of recruitment was blocked by GPIba antibodies.
Hence, in the absence of PAR signaling, only few platelets,
which are not fully spreading, are recruited by thrombin
binding to GPIba (Fig. 1, F and G). This demonstrates
that in our assay the major activation pathway involves
signaling via PARs.
We then sought to determine whether the major platelet
integrin aIIbb3, which is largely involved in most types of
platelet adhesion and aggregation (22), is also required for
adhesion in the nanosheet assay. This integrin is composed
of the glycoproteins IIb and IIIa, the latter of which binds
via its RGD binding domain to a-granule-secreted fibrin-
ogen, fibronectin, and von Willebrand factor. Hence, we
tested whether an RGDS peptide would compete with
platelet-secreted, nanosheet-adsorbed proteins for binding
to GPIIIa. In addition, we assessed the blocking effect of
the antibody ReoPro directed against the glycoprotein
IIb/IIIa receptor. As presented in Fig. S2, neither RGDS
nor ReoPro reduced the number of bound platelets or
seemed to abolish the formation of filopodial extensions.
However, they both blocked full spreading. RGDS blocked
spreading more strongly than ReoPro, indicating that other
integrins containing GPIIIa may be involved as well, or
that the concentration/accessibility of the ReoPro antibody
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FIGURE 1 Nanosheet-adsorbed thrombin acti-
vates platelet adhesion with high specificity.
(A and B) Time course of platelet adhesion. Plate-
lets were incubated with thrombin-coated nano-
sheets (10 U/ml) at 37C for various time periods
(as indicated) and washed. The adsorbed platelets
were imaged by fluorescence microscopy and visu-
alized by means of the lipophilic fluorescent dye
TMA-DPH. For quantification of adsorption
kinetics, the area covered by platelets was deter-
mined and plotted against the incubation time.
Area coverage includes all platelet stages on the
pathway to full spreading. Dotted, open, and solid
arrows mark an adsorbed platelet, a bound platelet
with filopodial extensions, and a fully spread
platelet, respectively (see also magnified views
shown at different scalings). (C) Nanosheets were
coated with 10 U/ml thrombin or thrombin was re-
placed by 3% BSA. The incubation time on the
nanosheets was 10 min. (D) Nanosheets coated
with 10 U/ml thrombin were incubated for
15 min at 37C with or without 10 U/ml of the
thrombin inhibitor hirudin. After two washing
steps, the platelets were added to the nanosheets
for a 10-min incubation. (E) Platelets were treated
for 15 min at 37C with or without 20 mM
SCH79797, which inhibits the PAR-1 receptor
for thrombin binding. The platelets were then
incubated for 10 min with nanosheets coated
with 10 U/ml thrombin. (F and G) Blocking of
the thrombin receptor GPIba and application of
the thrombin inhibitor PPACK (which is not
supposed to interfere with binding of GPIba to
thrombin). Before the platelets were exposed for
10 min to the 10 U/ml thrombin-coated nano-
sheets, 15-min incubations at 37C were per-
formed. Platelets were treated with control solutions or 10 mg/ml anti-GPIba, and nanosheets were incubated with or without 20 mM PPACK, followed
by two washing steps. (F) Images from the different conditions showing that anti-GPIba alone had no effect but the combined treatment of antibody and
PPACK strongly inhibited platelet adhesion. PPACK alone allowed a minor population of platelets to bind (see also magnified views); for quantification
see panel G. Please note that in the absence of thrombin or at very low thrombin concentrations (see also Figs. 3 and 6), virtually no adhesion occurs, demon-
strating that the nanosheets themselves do not activate platelets. All images are shown at arbitrary scalings. Values are given as the mean5 SE (n ¼ 3–4
independent experiments).
Sensitivity for Platelet Spreading 1859is not sufficient to produce the same inhibition effect as the
smaller and more highly concentrated RGDS peptide.
However, the data suggest that integrin aIIbb3 is the major
adhesion molecule used by platelets for spreading out under
these conditions.
A hallmark for platelet activation is the clustering of in-
tegrin aIIbb3 (23). To determine whether clustering would
also occur under our experimental conditions, we immuno-
stained the platelets for GPIIb. As shown in Fig. S3, the
staining was spotty but the signals were too blurry to clearly
assess the degree of integrin clustering. Therefore, we
turned to isoSTED microscopy (16), which provides
a several-fold higher resolution in both the lateral and axial
dimensions. This higher resolution allows for lateral resolu-
tion of the dense clusters in the plane of the membrane, and
axial resolution of the basal and apical membranes, which
after spreading are only a few 100 nm apart (i.e., below
the resolution limit of a conventional microscope). As pre-
sented in Fig. 2, isoSTED microscopy readily resolved thetwo membranes and thereby allowed the analysis of cluster
size and density in the adherent membrane. The integrin was
highly concentrated in ~58 nm large clusters at a density of
34 clusters per mm2, in line with our assumption that nano-
sheet-adsorbed thrombin is capable of triggering platelet
activation. In summary, the data show that thrombin-coated
nanosheets provide functionalized surfaces that can induce
platelet adhesion and spreading with high specificity.
So far, the data demonstrate that thrombin-coated nano-
sheets specifically trigger platelet adhesion. Moreover, in
10 min and at a coating concentration of 10 U/ml, the cell
spreading process is completed. We next characterized the
dose-response relationship, keeping the incubation time
constant at 10 min but varying the coating concentration.
As shown in Fig. 3, lower coating concentrations gradually
diminished adhesion, indicating that the sensitivity of the
platelets varies over a wide range and/or that the greater
the number of PAR receptors cleaved by thrombin, the
stronger is the activation of intracellular signaling pathways.Biophysical Journal 100(8) 1855–1863
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FIGURE 3 Dose-response relationship for platelet adhesion. Platelets
were incubated for 10 min at 37C with nanosheets coated with thrombin
in concentrations ranging from 0.01 to 20 U/ml, and platelet area coverage
was plotted against the thrombin coating concentration. Values are given as
the mean5 SE (n ¼ 3–7 independent experiments).
FIGURE 2 Clustering of integrin aIIbb3 indicates platelet activation.
After stimulation for 10 min on 10 U/ml-coated nanosheets, the platelets
were fixed, immunostained with an antibody raised against GPIIb, and
imaged by isoSTED microscopy. GPIIb staining reveals the distribution
of the integrin complex aIIbb3, which was further analyzed in the basal
adherent membrane. Upper panel: An xz scan illustrating the microscopic
separation of the apical and basal plasma membranes (scale bars: 500 nm
for both the x and z directions). Lower panel: An xy scan from a different
sample, showing basal plasma membranes recorded for visualization and
analysis of the integrin aIIbb3 distribution. An average cluster size of
58 5 5 nm and cluster density of 345 4 clusters per mm2 (n ¼ 12 cells)
are revealed. Values are given as the mean 5 SD. Scale bar: 1 mm. The
look-up table illustrates intensities from 0 to 1 a.u. displayed as black
and white, respectively.
1860 Okamura et al.This would lead to an overall faster response of more cells,
which in turn would result in larger surface coverage.
To characterize the sensitivity of the platelets in more
detail, we further sought to determine the number of mole-
cules with which a platelet establishes contact, and whether
the response at low thrombin concentrations depends on the
incubation time.
To obtain the number of thrombin molecules per platelet,
we measured the thrombin density on the nanosheets and the
size of the platelet-nanosheet contact area. For the thrombin
density, we determined the amount of nanosheet adsorbed
protein by measuring the adsorbed protein directly on
detachable nanosheets and the loss of protein from the
coating solution (for example, 0.25 U/ml would yield a value
of 10.1 ng; Fig. 4 A). When we corrected for protein aggre-
gation at the rim of the nanosheets (Fig. S4), we obtained
a protein surface concentration of 60.1 ag/mm2, or 4.8 ag
thrombin/mm2 taking into account the percentage of
thrombin in the coating solution (7.96%; see also Fig. S5).
At a molecular mass of 36,500 g/mol, this corresponds toBiophysical Journal 100(8) 1855–186379 adsorbed thrombin molecules per mm2. However, not
all molecules are active, as random adsorption should shield
the reactive center of a large percentage of them. To obtain
the percentage of inactive molecules, we compared the
proteolytic activity of free and adsorbed thrombin using
a small, cleavable substrate. As presented in Fig. 4 B, only
29% of the maximal activity was observed after adsorption,
suggesting that ~70% of the molecules are adsorbed in an
orientation that does not allow the thrombins to exert their
cleavage activity on the target receptor. The percentage of
thrombin that cannot be reached by the PAR receptors is
probably even higher, as adsorbed thrombin molecules are
more accessible to a freely diffusing small substrate than
to a bulky receptor in a platelet membrane. However, using
this experiment as a reference, we estimate that the surface
concentration of active thrombin molecules is <23 mole-
cules per mm2 at a coating concentration of 0.25 U/ml.
We determined the contact area of platelets using TIRF
microscopy, which images the part of the platelet membrane
that is in contact with the nanosheet (Fig. 5). Online record-
ings revealed that after they settled down to the nanosheets,
the platelets immediately started to spread in the presence of
thrombin (data not shown). Therefore, we settled platelets
down onto thrombin-free nanosheets, allowing contact
without stimulation, and simulating the starting point just
before activation. The platelets were imaged under two
illumination modes (Fig. 5 A). Using epifluorescence
microscopy, we imaged all platelets present. We then
recorded the same field of view by applying TIRF micros-
copy and illuminating only the first few 100 nm near the
glass-water interface with the platelet contact area, and visu-
alized the footprints of the same platelets observed with
epifluorescence microscopy. The footprints were outlined
and their size was calculated, yielding a value of
0.47 mm2. Consequently, at a surface density of, e.g., 23
accessible thrombin molecules per mm2, the average platelet
has contact with 11 molecules. Correspondingly, using the
AB
FIGURE 4 Amount of nanosheet-adsorbed
protein and thrombin activity after adsorption.
(A) Quantification of nanosheet-adsorbed protein.
Detachable nanosheets were coated overnight
with a fluorescently labeled thrombin solution of
a protein concentration as indicated on the x axis
of the graph. After incubation, the coating solution
was collected and the nanosheets were detached
from the coverslip. To determine the amount of
adsorbed protein, fluorescence at 580 nm was
measured, with the coating solutions (before and
after coating) and detached nanosheets used as
samples. Loss of protein from the coating solution
was calculated (corresponding to the adsorbed
protein) and averaged with the amount of adsorbed
protein measured directly from the nanosheets.
The averaged values were used for plotting. The
graph shows averaged individual curves from
several experiments, and the magnified view shows
the linear range of the graph. Values are given as
the mean 5 SE (n ¼ 4). To obtain the amount of
adsorbed protein at the respective coating concen-
tration, values were obtained from regression lines
fitted to the linear ranges of the graphs from the individual experiments (e.g., for 0.25 U/ml, a value of 10.1 ng/nanosheet (n ¼ 4) was obtained). (B)
Accessibility of the reactive center from adsorbed thrombin molecules. Thrombin activity was assayed by using the cleavable chromogenic substrate
N-(p-tosyl)-Gly-Pro-Arg-p-nitroanilide. A comparison of the activities of soluble and adsorbed thrombin (placing detached nanosheets into the spectropho-
tometer) shows that adsorption caused a decrease in activity to 29%. This suggests that thrombin adsorbs to the nanosheet in random orientations and that
only 29% of the thrombin molecules have free access to the cleavable substrate.
Sensitivity for Platelet Spreading 1861same calculation, we obtained values of<1, 2, 4, 22, 43, and
108 molecules for 0.01, 0.05, 0.1, 0.5, 1, and 2.5 U/ml,
respectively. Most likely, the actual molecule numbers are
even lower, because we may have overestimated the size
of the accessible thrombin fraction (Fig. 4 B; see above)
and not all thrombin molecules in the reconstituted
thrombin solution are expected to be active (only 88% of
human thrombin purified from plasma is active (24), and
~10% of the activity is lost upon freezing and thawing
(data not shown)). However, the data show that at a coating
concentration of 0.25 U/ml, significant adhesion can be
observed (Fig. 3), and that ~10 molecules are sufficient
for platelet spreading in 10 min.
To determine whether the adhesion response is also time-
dependent, we studied adhesion at low thrombin concentra-
tions after 5- or 30-min incubations (Fig. 6). As presented in
Fig. 6, the sensitivity for irreversible cell spreading is also
time-dependent, and even <10 molecules can induce cell
spreading if the incubation time is increased to 30 min.
As outlined above, the values indicating the molecule
number per platelet are somewhat overestimated. On the
other hand, stochastic distribution of adsorbed molecules
may lead to a variable distribution of molecules per platelet,
and it is possible that platelets with more than the average
molecule density are preferentially activated. However,
taken together, our results indicate that only a few thrombins
are sufficient for platelet spreading. It is possible that only
one molecule would suffice for extraordinarily long incuba-
tion times of several hours; however, this would most likely
play no role under physiological conditions.It was previously demonstrated that in solution the sole
platelet activation requires a concentration that is equivalent
to ~1200 thrombin molecules per platelet (6). Hence, in
steady state, at most 1200 thrombin molecules bind to the
entire surface of one platelet. However, as outlined in the
Introduction, the number of acting molecules cannot be
determined because it is unclear how many free thrombins
are in equilibrium with PAR-receptor-bound thrombins. In
this study, we defined the number required for platelet adhe-
sion on a surface with immobilized thrombin molecules. In
fact, <10 molecules are sufficient, and although this is not
directly comparable to the situation in solution, it is much
less than one might have expected.
There are three possible explanations for this high sensi-
tivity. First, as in vivo, in our assay the reaction occurs at
a thrombin-platelet interface at which thrombin molecules
and platelet receptors orient like in a solid-state interaction.
The entropy change for the thrombin-platelet receptor
complex formation is minimized in this configuration, re-
sulting in an acceleration of the reaction kinetics. This is
in line with the previous observation that another cell activa-
tion mechanism occurring in the solid-state configuration
had a similarly low sensitivity of 10 antigen molecules
required for mature immunological synapse formation
(25). Second, thrombin is a protease that is capable of acti-
vating more than one receptor irreversibly. At first glance it
seems odd that a receptor can be irreversibly activated, and
it is unclear why PARs have evolved in this direction.
However, the mechanism allows one immobilized thrombin
to activate several receptors quickly, one after another. ThisBiophysical Journal 100(8) 1855–1863
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FIGURE 6 Platelet sensitivity for irreversible adhesion. Platelets were
incubated for 5 min (blue line) or 30 min (green line) at 37C with nano-
sheets coated with thrombin in concentrations ranging from 0.01 to
2.5 U/ml, and surface coverage was plotted against the thrombin coating
concentration. For comparison, data from Fig. 3 are also shown (10 min
incubations, red line). For plotting, the U/ml values (upper x axis) were
converted into active thrombin molecules per platelet contact area (lower
x axis; for explanation see text). Values are given as the mean 5 SE
(n ¼ 3–7 independent experiments for platelet adhesion, and n ¼ 4 for
determination of molecule number).
A
B
FIGURE 5 Platelet footprints imaged by TIRF microscopy. (A) Platelets
settled down onto BSA-coated coverslips were visualized with the
membrane staining dye FM1-43 and imaged by epifluorescence (left) and
TIRF microscopy (right). (B) Left: Magnified view from the overlay of
the epifluorescence image (green) and the TIRF micrograph (red). Nonac-
tivated platelets and their corresponding footprints were identified, out-
lined, and further processed (right panel). Determination of their average
size yielded a value of 0.475 0.04 mm2 (mean5 SE, n ¼ 3 independent
experiments; 181–413 footprints were analyzed for each experiment).
1862 Okamura et al.is not possible in solution, because after cleavage thrombin
is released into the solution, diffusing away from the
membrane. Third, 10 immobilized molecules acting on
a small membrane patch (the platelet contact site) might
trigger locally higher signals than would 10 soluble mole-
cules stochastically distributed over the cell membrane.
For these reasons, we suggest that immobilization of the
proteolytically active thrombin in conjunction with the
PAR reaction pathway can maximize the effect of a few
signaling molecules, resulting in a higher sensitivity.
Hence, although they depend on the same key players,
interactions in solution or in the solid state involve different
steps that become rate-limiting for the overall reaction
kinetics. This has implications for the interpretation of
in vitro coagulation tests. Recently, Mann et al. (26) pointed
out that all in vitro coagulation tests are limited due to the
absence of contributing vasculature and surrounding tissue,
which would mediate the solid-state interaction described
here. Given that in vivo testing in humans is precluded
because of the high pathophysiological risks involved, the
described system could be useful for generating more-phys-
iological assay conditions to evaluate the effects of antith-
rombotic drugs or the antithrombotic properties of the
surfaces of artificial organs.
In summary, our findings demonstrate that only a few
signaling molecules are sufficient to achieve irreversibleBiophysical Journal 100(8) 1855–1863platelet adhesion. Similarly, 10 molecules activate T-cell
immunological synapse formation (25). This parallel may
indicate another biological significance. Sensory systems
are able to detect even single molecules (25,27) or photons
(28), but false registrations are tolerable when individual
signals are integrated and neuronally processed. This is
different for irreversible cell activation, in which case
single-molecule responses can generate undesired effects
if the signaling molecule accidentally marks a site at which
the cellular function is not required or would even be harm-
ful. Hence, it is possible that nature has balanced these
systems to minimize false activation while still allowing
for the highest sensitivity, resulting in the requirement of
only a few signaling molecules per cell.SUPPORTING MATERIAL
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